| Stage | SHAK | % of rev | HLNE | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $418M | 100.00% | $275M | 100.00% | SHAK ×1.52 |
| Gross profit | $200M | 47.92% | $168M | 60.90% | HLNE +13.0pp |
| Operating income | $21M | 4.97% | $126M | 45.93% | HLNE +41.0pp |
| Pre-tax income | $23M | 5.46% | $150M | 54.47% | HLNE +49.0pp |
| Net income | $17M | 4.04% | $125M | 45.36% | HLNE +41.3pp |
| Stage | SHAK | HLNE | Gap · A − B |
|---|---|---|---|
| Revenue | $418M100.00% | $275M100.00% | SHAK ×1.52 |
| Gross profit | 47.92%$200M | 60.90%$168M | HLNE +13.0pp |
| Operating income | 4.97%$21M | 45.93%$126M | HLNE +41.0pp |
| Pre-tax income | 5.46%$23M | 54.47%$150M | HLNE +49.0pp |
| Net income |
| 4.04%$17M |
| 45.36%$125M |
| HLNE +41.3pp |
No shared counterparties.